v3.26.1
SCHEDULE OF DISAGGREGATED BY PRODUCT (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenues $ 343,639 $ 399,964 $ 10,258
Losartan Potassium Oral Suspension [Member]        
Disaggregation of Revenue [Line Items]        
Total revenues 343,639 399,964
Pharmaceutical Product Resale [Member]        
Disaggregation of Revenue [Line Items]        
Total revenues $ 10,258